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Genome-wide associations studies (GWAS) have identi-
fied >400 loci associated with common human diseases.
Despite the extraordinary achievement that these results
represent, several questions remain unanswered:
(i) What is the contribution of rare variants to common
diseases not addressed by GWAS? (ii) What are the
functional variants underlying the GWAS associations?
To answer these questions, we first explored the role
of common and rare variants in morbid obesity
(BMI>40) by identifying all the variants in the intervals
of two endocannabinoid metabolic genes (MGLL and
FAAH) using targeted sequencing. We used two differ-
ent statistical approaches (single marker tests and col-
lapsed markers tests) to identify variants in four
intervals associated with high BMI. The majority of the
associated variants are located in promoter sequences or
in predicted transcriptional enhancers, suggesting their
regulatory role. Additionally, we demonstrate that the
set of rare variants in the FAAH promoter associated
with BMI are also associated with an increased level of
anandamide, a FAAH substrate, further suggesting a
functional role in obesity. In a second study, we exam-
ined one of the most compelling GWAS that had identi-
fied SNPs in the 9p21 gene desert associated with
coronary artery disease (CAD) and Type 2 diabetes
(T2D). We identified 33 enhancers in 9p21; the interval
is the second most dense gene-desert for predicted
enhancers and is six times denser than the whole gen-
ome. The activity of three of these enhancers is affected
by regulatory variants that show allelic differences in
DNA-protein affinity and are strongly associated with
e i t h e rC A Do rT 2 D .S o m eo ft h e s ev a r i a n t sa r ep r e -
dicted to disrupt the transcription-binding site relevant
to CAD biology. Our study shows that the 9p21 gene
desert is significantly enriched in enhancer elements and
suggests the associations with CAD and T2D likely
result from the cumulative contributions of multiple
regulatory variants.
Taken together, our studies show that a comprehen-
sive approach of human genetics that integrates rare
variants and functional knowledge, such as regulatory
elements or metabolic and cell-specific effects, can
leverage the findings of GWAS and lead to a deeper
functional understanding of the role of genetic variation
in human diseases.
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